Veracyte | VCYT - 税前利润



金融业
股票价格
USD
资产
USD 1.44B
现金及等价物
USD 263.14M
销售成本
USD 38.49M
流动资产
USD 522.18M
流动负债
USD 56.12M
债务
USD 39.65M
EBIT
USD 19.08M
EBITDA
USD 42.8M
员工
824
EPS每股收益
USD 0.52
股本和储备
USD 1.34B
销售毛利
USD 101.16M
债务利息支出
USD 2K
利息收入
USD 3.48M
贷款资金
USD 0
市值
USD 2.59B
净收入
USD 28.71M
营业费用
USD 119.99M
营业利润
USD 19.08M
普通股股本
USD 79.79M
PE价格收益
24.89
税前利润
USD 29.97M
销售收入
USD 139.07M
销售和管理费用
USD 50.84M
股票
USD 21.42M
贸易债权人
USD 6.91M
应收帐款人
USD 50.11M


税前利润 更改 日
Agenus USD -10.61M 263.52M 2025-12
Agilent USD 442M 1000K 2025-09
Anika Therapeutics USD 764K 3M 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
Bruker USD -72.6M 73.1M 2025-09
Heron Therapeutics USD -2.95M 14.54M 2025-12
Illumina USD 157M 220M 2026-03
Intrexon USD -60.48M 27.09M 2024-06
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Laboratory Of America USD 8.73B 8.54B 2026-03
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Siemens EUR 2.39B 505M 2025-09
Sonic Healthcare AUD 402.01M 53.16M 2025-06
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veracyte USD 29.97M 10.66M 2026-03
Waters USD 264.18M 94.06M 2025-12